Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Mult Scler. 2008 Jun 5;14(6):770–778. doi: 10.1177/1352458507088104

Table 1.

Correlation between new contrast enhancing lesions per scan over 6 months and relapse rate over 6 months

Trial n Correlation
(Spearman)
p-value
(Spearman)
Correlation
(Pearson)
95% CI
(Pearson)
Overall 208 0.21 0.002 0.11 −0.03, 0.24
A 1 - - - -
B 4 −0.26 > 0.20 −0.45 −0.99, 0.90
C 3 - - - -
D 11 0.07 > 0.20 0.29 −0.38, 0.76
E 33 0.15 > 0.20 −0.02 −0.36, 0.33
F 44 0.25 0.10 0.09 −0.21, 0.38
G 27 0.05 > 0.20 −0.01 −0.39, 0.37
H 13 0.17 > 0.20 0.01 −0.54, 0.56
I 18 0.29 > 0.20 0.21 −0.28, 0.62
J 26 0.16 > 0.20 −0.09 −0.46, 0.31
K 28 0.30 0.12 0.17 −0.22, 0.51
Combined* 204 0.19 0.01 0.06 −0.09, 0.20
*

Weighted mean correlation, trials A and C excluded (see text).